SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SALVADORI, Severo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.228
AS - Asia 11.691
EU - Europa 6.421
SA - Sud America 1.717
Continente sconosciuto - Info sul continente non disponibili 273
AF - Africa 243
OC - Oceania 22
Totale 47.595
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.666
SG - Singapore 4.285
CN - Cina 3.115
UA - Ucraina 1.317
BR - Brasile 1.312
DE - Germania 1.299
VN - Vietnam 1.134
HK - Hong Kong 1.048
IT - Italia 887
TR - Turchia 884
GB - Regno Unito 823
FI - Finlandia 517
FR - Francia 409
SE - Svezia 391
CA - Canada 294
RU - Federazione Russa 281
JP - Giappone 226
BD - Bangladesh 221
IN - India 207
MX - Messico 173
AR - Argentina 125
PL - Polonia 121
ZA - Sudafrica 89
ID - Indonesia 80
BE - Belgio 79
IQ - Iraq 79
CO - Colombia 78
PK - Pakistan 65
NL - Olanda 63
ES - Italia 59
EC - Ecuador 55
UZ - Uzbekistan 47
PH - Filippine 45
VE - Venezuela 42
SA - Arabia Saudita 35
LT - Lituania 34
CL - Cile 32
MA - Marocco 32
TN - Tunisia 30
MY - Malesia 29
AE - Emirati Arabi Uniti 24
AT - Austria 24
PY - Paraguay 22
IR - Iran 21
JM - Giamaica 21
KR - Corea 21
EG - Egitto 20
KE - Kenya 20
PE - Perù 20
UY - Uruguay 18
CZ - Repubblica Ceca 17
IL - Israele 17
JO - Giordania 17
RO - Romania 15
AU - Australia 14
DZ - Algeria 13
HN - Honduras 13
CR - Costa Rica 12
NP - Nepal 12
AL - Albania 11
CH - Svizzera 11
BO - Bolivia 10
ET - Etiopia 9
LB - Libano 9
TT - Trinidad e Tobago 9
BH - Bahrain 8
GT - Guatemala 8
TH - Thailandia 8
AZ - Azerbaigian 7
IE - Irlanda 7
PA - Panama 7
GR - Grecia 6
NZ - Nuova Zelanda 6
SN - Senegal 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EU - Europa 5
HR - Croazia 5
KZ - Kazakistan 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
QA - Qatar 5
SV - El Salvador 5
DK - Danimarca 4
HU - Ungheria 4
KG - Kirghizistan 4
NI - Nicaragua 4
NO - Norvegia 4
PR - Porto Rico 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BJ - Benin 3
CI - Costa d'Avorio 3
LV - Lettonia 3
LY - Libia 3
MM - Myanmar 3
MT - Malta 3
NG - Nigeria 3
RS - Serbia 3
Totale 47.276
Salva come PNG Salva come JPEG
Città #
Ashburn 2.903
Singapore 2.722
Fairfield 2.364
Woodbridge 2.350
San Jose 1.625
Houston 1.600
Jacksonville 1.434
Ann Arbor 1.248
Chandler 1.102
Hong Kong 1.035
Santa Clara 1.034
Beijing 1.007
Seattle 930
Wilmington 848
Cambridge 789
Dallas 561
Council Bluffs 538
Los Angeles 460
Izmir 441
Nanjing 415
New York 395
Ho Chi Minh City 372
Munich 310
Princeton 277
Hanoi 259
San Diego 238
Lauterbourg 229
Tokyo 223
Milan 215
Boardman 196
Dearborn 196
Helsinki 169
Ferrara 155
São Paulo 129
Nanchang 122
Brooklyn 119
Falkenstein 117
Shenyang 116
Hefei 110
Orem 110
Warsaw 109
Mexico City 105
Shanghai 105
Denver 103
Chicago 99
London 98
San Francisco 95
Montreal 93
Addison 89
Toronto 89
Atlanta 88
Phoenix 84
Falls Church 81
Turku 78
San Mateo 76
Brussels 74
Hebei 72
Tianjin 72
Auburn Hills 65
Bremen 63
Jiaxing 63
Jinan 63
Buffalo 62
Changsha 62
Boston 61
Haiphong 57
Frankfurt am Main 56
Da Nang 51
Mountain View 49
The Dalles 48
Kunming 47
Moscow 47
Stockholm 47
Johannesburg 45
Philadelphia 45
Washington 45
Chennai 42
Redwood City 41
Tashkent 41
Manchester 39
Rio de Janeiro 39
Zhengzhou 39
Poplar 38
Guangzhou 36
Norwalk 36
Ningbo 35
Belo Horizonte 34
Bologna 31
Baghdad 29
Hải Dương 29
Columbus 28
Dhaka 26
Biên Hòa 25
Charlotte 25
Medellín 25
Curitiba 24
Jakarta 24
Mumbai 24
Tappahannock 24
Des Moines 23
Totale 32.806
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.253
Dermorphin inhibits spinal nociceptive flexion reflex in humans 427
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 401
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 344
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 343
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 309
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 305
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 300
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 298
A cyclic peptide T analogue with high chemotactic activity 297
The effects of dermorphin on the endocrine system in man 290
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 283
A new selective antagonist of the nociceptin receptor 282
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 277
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 272
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 268
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 264
A new ligand for the urotensin II receptor 261
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 261
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 257
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 254
2-Bromoamides as Synthons for Pseudopeptides Containing Aminodicarboxy Units 252
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 249
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 248
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 248
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 248
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 247
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 245
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 245
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 240
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 239
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 239
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 235
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 234
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 234
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 233
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 233
Physicochemical stability of cabazitaxel and docetaxel solutions 230
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 228
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 226
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 226
Neuropeptide S receptor ligands: a patent review (2005-2016) 225
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 224
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 224
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 223
Pharmacological characterization of tachykinin tetrabranched derivatives 222
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 216
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 215
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 215
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 214
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 211
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 210
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 210
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 209
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 209
Pharmacological characterization of nociceptin receptor: an in vitro study 208
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. 207
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 207
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 207
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 205
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 205
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 205
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 205
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 204
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 204
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 203
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 203
Critical role for prokineticin 2 in CNS autoimmunity 202
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 202
Structure-activity study at positions 3 and 4 of human neuropeptide S. 200
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 198
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 198
Design of d-opioid peptide antagonists for emerging drug applications 194
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 193
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 191
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 190
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 190
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 189
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 188
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 188
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 186
Synthetic Approach to non-Isosteric Peptidomimetics Related to Human Endothelin 186
Structure–activity relationships of cyclic and linear peptide T analogues 185
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 185
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 185
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 184
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 184
6-N,N-dimethylamino-2,3-naphthalimide: A new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides 183
Nociceptin/orphanin FQ receptor ligands 183
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands 182
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 181
Structure-activity relationship study on human urotensin II 181
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores 180
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 180
Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders. 179
Characterization of N,N(Me)(2)-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist 178
Somatostatin Inhibits the Dermorphin-Stimulated Thyrotropin Release in Man 178
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 177
Synthesis and biological activity of carboxyl terminally extended dermorphins 177
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation 176
Totale 23.668
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.611
Totale 212.294
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.578 0 0 230 211 230 135 136 170 114 228 224 900
2022/20232.733 297 96 90 335 463 380 148 272 388 16 143 105
2023/20241.291 150 183 94 32 103 233 51 82 17 22 32 292
2024/20255.005 141 106 410 141 637 458 156 346 682 512 749 667
2025/202614.884 1.509 666 1.429 2.046 2.032 995 1.674 739 1.380 1.686 505 223
2026/20273.409 1.855 1.014 540 0 0 0 0 0 0 0 0 0
Totale 47.595